Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02606721 · ClinicalTrials.gov registry record
Food Allergy Challenge Diagnostic Study
A clinical trial, sponsored by ORA.
- Completed
- Registry status
- 6
- Enrollment target
NCT02606721: Completed study, sponsored by ORA.
NCT02606721 is a clinical trial that has completed, run by ORA. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02606721 has completed, sponsored by ORA.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to correlate various diagnostic measurements taken during an escalating dose oral food challenge to the subject's response. This study will investigate whether non invasive objective biomarkers can indicate a positive response to an escalating dose OFC before a systemic reaction occurs.
Primary Outcome
Correlation between imaging measurements taken before, during, and after oral food challenge to outcome of challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-10 |
What the finished NCT02606721 record still lists
NCT02606721 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02606721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02606721 about?
NCT02606721 is a clinical study titled "Food Allergy Challenge Diagnostic Study". The objective of this study is to correlate various diagnostic measurements taken during an escalating dose oral food challenge to the subject's response. This study will investigate whether non invasive objective biomarkers can indicate a positive response to an escalating dose OFC before a systemi...
What is the current status of trial NCT02606721?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2016-03. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02606721?
This trial is sponsored by ORA, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia